Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer

Deepa Maheswari Narasimhulu, Michaela E. McGree, Amy L. Weaver, Aminah Jatoi, Nathan K. LeBrasseur, Gretchen E. Glaser, Carrie L. Langstraat, Matthew S. Block, Amanika Kumar

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences